Abstract
The chapter “Medical Retina and Uveitis” provides the reader with an overview of the clinical features and management of retinal diseases, notably: age-related macular degeneration, diabetic eye disease, vascular disease, hypertensive retinopathy and retinitis pigmentosa. In addition, it covers infective and inflammatory conditions leading to posterior uveitis (e.g. sarcoidosis, Behcet’s disease, tuberculosis and syphilis). The chapter further discusses pathology, imaging, and visualization of retinal diseases and will prove informative for ophthalmologists, optometrists and technicians.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study report number 3. Ophthalmology. 2000;107(12):2224–32.
Donoso LA, Vrabec T, Kuivaniemi H. The role of complement factor H in age-related macular degeneration: a review. Surv Ophthalmol. 2010;55(3):227–46.
Toomey CB, Johnson LV, Bowes Rickman C. Complement factor H in AMD: bridging genetic associations and pathobiology. Prog Retin Eye Res. 2018;62:38–57.
Klein RJ, Zeiss C, Chew EY, Tsai J-Y, Sackler RS, Haynes C, et al. Complement factor H polymorphism in age-related macular degeneration. Science (New York). 2005;308(5720):385–9.
Thakkinstian A, Han P, McEvoy M, Smith W, Hoh J, Magnusson K, et al. Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Hum Mol Genet. 2006;15(18):2784–90.
The Age-Related Eye Disease Study Research Group. The age-related eye disease study (AREDS): design implications AREDS report no. 1. Control Clin Trials. 1999;20(6):573–600.
Age-Related Eye Disease Study Research Group. A randomized placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119(10):1417–36.
Chew EY, Clemons T, SanGiovanni JP, Danis R, Domalpally A, McBee W, et al. The age-related eye disease study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1). Ophthalmology. 2012;119(11):2282–9.
Rufai SR, Almuhtaseb H, Paul RM, Stuart BL, Kendrick T, Lee H, et al. A systematic review to assess the ‘treat-and-extend’ dosing regimen for neovascular age-related macular degeneration using ranibizumab. Eye. 2017;31:1337.
The Central Vein Occlusion Study Group. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N report. Ophthalmology. 1995;102(10):1434–44.
The Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol (Chicago, IL: 1960). 1997;115(4):486–91.
Hayreh SS, Zimmerman MB, Kimura A, Sanon A. Central retinal artery occlusion. Retinal survival time. Exp Eye Res. 2004;78(3):723–36.
Hayreh SS, Kolder HE, Weingeist TA. Central retinal artery occlusion and retinal tolerance time. Ophthalmology. 1980;87(1):75–8.
Hayreh SS, Weingeist TA. Experimental occlusion of the central artery of the retina. I. Ophthalmoscopic and fluorescein fundus angiographic studies. Br J Ophthalmol. 1980;64(12):896–912.
Hayreh SS, Jonas JB. Optic disk and retinal nerve fiber layer damage after transient central retinal artery occlusion: an experimental study in rhesus monkeys. Am J Ophthalmol. 2000;129(6):786–95.
Brito-Garcia N, Del Pino-Sedeno T, Trujillo-Martin MM, Coco RM, Rodriguez de la Rua E, Del Cura-Gonzalez I, et al. Effectiveness and safety of nutritional supplements in the treatment of hereditary retinal dystrophies: a systematic review. Eye (London). 2017;31(2):273–85.
Berson EL, Rosner B, Sandberg MA, Hayes KC, Nicholson BW, Weigel-DiFranco C, et al. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol (Chicago, IL: 1960). 1993;111(6):761–72.
Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Moser A, Brockhurst RJ, et al. Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses. Arch Ophthalmol (Chicago, IL: 1960). 2004;122(9):1306–14.
Bahrami H, Melia M, Dagnelie G. Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289]. BMC Ophthalmol. 2006;6:23.
Rotenstreich Y, Belkin M, Sadetzki S, Chetrit A, Ferman-Attar G, Sher I, et al. Treatment with 9-cis beta-carotene-rich powder in patients with retinitis pigmentosa: a randomized crossover trial. JAMA Ophthalmol. 2013;131(8):985–92.
Park JE, Kim YS, Kang MJ, Kim CJ, Han CH, Lee SM, et al. Prevalence, incidence, and mortality of sarcoidosis in Korea, 2003–2015: a nationwide population-based study. Respir Med. 2018;144S:S28–34.
Erdal BS, Clymer BD, Yildiz VO, Julian MW, Crouser ED. Unexpectedly high prevalence of sarcoidosis in a representative U.S. Metropolitan population. Respir Med. 2012;106(6):893–9.
Gerke AK, Judson MA, Cozier YC, Culver DA, Koth LL. Disease burden and variability in sarcoidosis. Ann Am Thorac Soc. 2017;14(Suppl 6):S421–8.
Gribbin J, Hubbard RB, Jeune IL, Smith CJP, West J, Tata LJ. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax. 2006;61(11):980–5.
Suzuki Kurokawa M, Suzuki N. Behcet’s disease. Clin Exp Med. 2004;4(1):10–20.
Thompson MJ, Albert DM. Ocular tuberculosis. Arch Ophthalmol. 2005;123(6):844–9.
Shakarchi FI. Ocular tuberculosis: current perspectives. Clin Ophthalmol (Auckland, NZ). 2015;9:2223–7.
Das T, Pathengay A, Hussain N, Biswas J. Eales’ disease: diagnosis and management. Eye (London). 2010;24(3):472–82.
Atmaca LS, Batioglu F, Atmaca Sonmez P. A long-term follow-up of Eales’ disease. Ocul Immunol Inflamm. 2002;10(3):213–21.
Biswas J, Sharma T, Gopal L, Madhavan HN, Sulochana KN, Ramakrishnan S. Eales disease—an update. Surv Ophthalmol. 2002;47(3):197–214.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Yvon, C., Dey, M. (2020). Medical Retina and Uveitis. In: Liu, C., Lee, H. (eds) Fundamentals in Ophthalmic Practice . Springer, Cham. https://doi.org/10.1007/978-3-030-28841-9_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-28841-9_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-28840-2
Online ISBN: 978-3-030-28841-9
eBook Packages: MedicineMedicine (R0)